(Q42202078)

18 October 2017

title

A national reference for inactivated polio vaccine derived from Sabin strains in Japan (English)

1 reference

18 October 2017

1 reference

Haruko Shirato

1

1 reference

18 October 2017

Yuichi Someya

2

1 reference

18 October 2017

Masaki Ochiai

3

1 reference

18 October 2017

Yoshinobu Horiuchi

4

1 reference

18 October 2017

Motohide Takahashi

5

1 reference

18 October 2017

Naokazu Takeda

6

1 reference

18 October 2017

Kengo Wakabayashi

7

1 reference

18 October 2017

Yasumitsu Ouchi

8

1 reference

18 October 2017

Yoshihiro Ota

9

1 reference

18 October 2017

Yoshio Tano

10

1 reference

18 October 2017

Shinobu Abe

11

1 reference

18 October 2017

Shudo Yamazaki

12

1 reference

18 October 2017

Takaji Wakita

13

1 reference

18 October 2017

sIPV Evaluation Group of NIID-Virology II

14

1 reference

18 October 2017

language of work or name

English

0 references

publication date

30 July 2014

1 reference

18 October 2017

1 reference

18 October 2017

volume

32

1 reference

18 October 2017

issue

40

1 reference

18 October 2017

page(s)

5163-5169

1 reference

Emerging Concept of Poliomyelitis Infection

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Pathogenesis of poliomyelitis; reappraisal in the light of new data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Technology transfer of Sabin-IPV to new developing country markets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Development of inactivated poliovirus vaccine derived from Sabin strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Simplified Estimators for the Normal Distribution When Samples Are Singly Censored or Truncated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.065

10.1016/J.VACCINE.2014.07.065

7 January 2021

Identifiers

DOI

1 reference

18 October 2017

1 reference